- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Aridis Pharmaceuticals Inc.
Headquarters: San Jose, CA, United States
Website: http://www.aridispharma.com
Year Founded: 2003
Status: Public
Industry Sector: HealthTechnology
CEO: Vu L. Truong, PhD
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: 0
Exchange/Ticker 1: NASDAQ:ARDS
Exchange/Ticker 2: N/A
Latest Market Cap: $4,500
BioCentury | Nov 16, 2023
Discovery & Translation
Aldena’s JAK-1-selective siRNA; an aerosol mAb for SARS-CoV-2 and more
BioCentury’s roundup of translational innovations
BioCentury | Oct 21, 2020
Finance
Oct. 20 Quick Takes: AbSci raises $65M; plus Aptinyx, Synspira and Aridis
Casdin leads $65M round for AbSciProtein manufacturing company AbSci LLC said it raised $65 million in a series E round led by Casdin Capital. First-time backers Redmile Group and ArrowMark Partners
BioCentury | Oct 24, 2019
Company News
Management tracks: bluebird's Walsh departing as chief strategy officer; plus JDRF, Akcea, Rigel, Elicio and Progenity
BioCentury | Oct 11, 2019
Company News
Management tracks: Chan leaving FDA’s China office; plus Galera, Aridis and Palladio
BioCentury | Sep 3, 2019
Clinical News
Sept. 3 Clinical Quick Takes: Phase II failure for Aridis, plus Kura, Idorsia, Concert, PegBio
Items per page:
1 - 10 of 14